8 results
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... #Pharmacology #Smoking ... Cessation #Therapy #Comparison ... #Table #Agents
Low Attenuation pattern 
1. Lymphangiomyomatosis (LAM): uniform cysts in woman of child-bearing age; no history of
Low Attenuation pattern ... no history of smoking ... shaped cysts; smoking ... LowAttenuation #Cystic #Pattern ... #Comparison #Table
On the left some diseases with a nodular pattern.
1. Hypersensitivity pneumonitis: ill defined centrilobular nodules.
2. Miliary
with a nodular pattern ... nodules, notice sparing ... #NodularPattern ... #Differential #Comparison ... #Table #RadiologyAssistant
Low Attenuation pattern (2) 
1. Centrilobular emphysema: low attenuation areas without walls. Notice the centrilobular artery
Low Attenuation pattern ... walled cysts; smoking ... LowAttenuation #Cystic #Pattern ... #Comparison #Table
Pharmacotherapy for Smoking Cessation - Table of Short and Long-Acting Agents:

Long Acting: Nicotine Patch, Buproprion, Varenicline
Short
Pharmacotherapy for Smoking ... Cessation - Table ... #Pharmacology #Smoking ... Cessation #Therapy #Comparison ... #Table #Agents
The distribution of nodules shown on HRCT is the most important factor in making an accurate
important factor in making ... in the nodular pattern ... Pulmonary #HRCT #NodularPattern ... #Nodular #Pattern ... Perilymphatic #Comparison
Personality Disorders - Differential Diagnosis Algorithm
• Enduring pattern of experience and behaviour that deviates from cultural
Differential Diagnosis Algorithm ... • Enduring pattern ... is stable and of ... Histrionic - attention-seeking ... Differential #Diagnosis #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... event, follow ACC algorithm ... Stable patients ... Pulmonary: • Smoking ... postoperative cardiac events